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Abstract 
 
CHARACTERIZATION OF THE INTERACTIONS BETWEEN STAPHYLOCOCCAL 
PHAGE 80 ALPHA SCAFFOLD AND CAPSID PROTEINS 
By Laura Ann Klenow 
A thesis submitted in partial fulfillment of the requirement for the degree of Master of 
Science at Virginia Commonwealth University. 
 
Virginia Commonwealth University, 2015 
Major Director: Gail E. Christie, Ph.D. 
Professor, Department of Microbiology and Immunology 
 
Staphylococcal phage 80α can serve as a helper bacteriophage for a family of mobile 
genetic elements called Staphylococcus aureus pathogenicity islands (SaPIs). The 
prototype island, SaPI1, is able to hijack the 80α capsid assembly process and redirect 
capsid formation to yield smaller, phage-like transducing particles carrying SaPI DNA. 
Capsid size redirection is accomplished through two SaPI1-encoded gene products, 
CpmA and an alternate scaffold protein, CpmB. The normal 80α scaffold and the SaPI1 
CpmB scaffold share a small block of conserved residues at their C-termini, several of 
which had been shown to be essential for CpmB function. This led to the hypothesis that 
 the C-termini of both the phage and SaPI scaffolds interact in similar ways with the major 
capsid protein. The goal of this study was to test this hypothesis and to identify the amino 
acid residues at the capsid-scaffold interface, using a genetic approach.  
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Chapter 1 
Introduction 
 
Staphylococcus aureus virulence and mobile genetic elements 
  Staphylococcus aureus is a widespread Gram-positive bacterium that is commonly 
found as a normal inhabitant of human skin and the mucosal epithelia. It is estimated that 
20% of individuals’ anterior nares are persistently colonized, with approximately 30% of 
the population intermittently colonized (Gordon et al., 2008). While S. aureus is generally 
a commensal bacterium, it is in possession of a vast array of virulence factors and toxins 
that are capable of causing an assortment of systemic and local infections (Xia et al., 
2013). Antibiotic resistance in S. aureus arose two years after the introduction of 
methicillin and has been increasing in prevalence in the clinical setting since that time 
(Jevons, 1961). Nosocomial S. aureus infections are the second most reported hospital 
acquired infections and while the majority of resistant strains were reported in clinical 
settings, community acquired (CA)-MRSA cases, or incidents where the persons infected 
had no prior hospitalizations, are on the rise as well (Archer, 2008; Knox et al. 2015; 
Lowy, 2003).   
While antibiotic resistance is a valid concern, the pathogenicity of S. aureus ranges 
from causing local skin abscesses all the way to disseminated septic shock, due in large 
part to a host of over 20 known virulence factors (Archer, 1998). Virulence factors can be 
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acquired through the highly promiscuous nature of bacterial horizontal gene transfer 
(HGT). HGT is accomplished through a variety of mechanisms, as virulence genes and 
toxins are often carried by mobile genetic elements (MGEs) such as bacteriophages, 
pathogenicity islands, and plasmids (Novick, 2003). Along these lines, S. aureus can be 
parasitized by staphylococcal phage 80α, which on its own is able to transfer 
chromosomal and plasmid-encoded genes through generalized transduction (Dyer et al. 
1985). However, adding another layer of complexity to the issue is the fact that 80α can 
also mediate specific high-frequency transduction of Staphylococcus aureus 
pathogenicity islands (SaPIs) which also carry genes for several virulence factors, such 
as the toxic shock syndrome toxin (Novick, 2003).   
 
Bacteriophage 80α and the molecular pirate SaPI1 
      Staphylococcal bacteriophage 80α is a temperate, double-stranded DNA (dsDNA) 
phage of the family Siphoviridae (Christie et al,. 2010). The mature 80α virion has a 63 
nm diameter, icosahedral capsid with T=7 symmetry. Attached to the capsid is a 190 nm 
long non-contractile, flexuous tail with an elaborate baseplate that is studded with six tail 
fibers (Spilman et al., 2011). 80α is a temperate bacteriophage, meaning that it can reside 
as a stable lysogen integrated into the host staphylococcal chromosome, or alternatively 
infect the cell and cause lysis after a productive phage infection (Christie et al., 2010).  
 Most dsDNA, tailed bacteriophages replicate in a similar manner. After infecting a 
cell and shutting down certain host cell macromolecular synthesis processes in favor of 
preferentially producing phage components, a small, empty prohead structure is formed 
by the aggregation of scaffold-chaperoned capsid proteins (Rossman, 2013). Later in the 
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assembly process, the genome is packaged through the portal into the procapsid. DNA 
packaging is an energy consuming process and is powered by the small and large 
subunits of terminase, which are ATP dependent (Rossman, 2013). While the genome is 
packaged, the internal scaffolding protein exits and the procapsid expands to a larger, 
DNA-filled mature capsid (Prevelige et al., 2012). 
The staphylococcal phage 80α follows a similar pathway (Figure 1). The 80α 
capsid assembly pathway involves formation of an empty, transient procapsid composed 
of 415 copies of the major capsid protein, gene product (gp) 47; 100-200 copies of the 
scaffold protein, gp46; a portal protein, gp42; and approximately 20 copies of an 
uncharacterized minor capsid protein, gp44 (Tallent et al., 2007; Poliakov et al., 2008). 
Like other tailed dsDNA bacteriophages, the capsid protein of 80α shows a conformation 
similar to that first described in phage HK97, the so-called HK97 fold (Johnson, 2010). 
During procapsid assembly, scaffold protein gp46 serves as a chaperone for the 
aggregation of major capsid protein gp47. Both gp46 and gp47 are N-terminally cleaved 
by 13 and 14 residues, respectively, between phenylalanine and alanine residues within 
a conserved amino acid sequence motif (Poliakov et al., 2008). This cleavage is carried 
out by a host-encoded cysteine protease, phage-related ribosomal protease (Prp) (Wall 
et al., 2015). Procapsid expansion and maturation is dependent upon a conformational 
change involving a proline at residue 132 (P132) in gp47 (Spilman et al., 2011). 80α 
procapsid expansion involves dynamic remodeling of the surface gp47 proteins due to 
the rotational effects of P132 altering its angle in the spine helix of capsid, resulting in an 
expansion that roughly doubles the volume of the procapsid  (Spilman et al., 2011). 
Procapsid expansion occurs simultaneously with the release of gp46, and the headful
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Figure 1: Schematic of 80α capsid assembly and the SaPI1 CpmA and CpmB redirection of 80α capsid assembly.  
 
80α scaffolding protein, gp46, serves as a chaperone for the proper aggregation of major capsid protein, gp47. Upon DNA 
packaging, the procapsid expands to form a mature virion. In the presence of the SaPI1 encoded CpmA and CpmB capsid 
size redirection genes, SaPI1 forms a smaller procapsid, resulting in a transducing particle that is approximately one-third 
the volume of the mature 80α virion.   
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packaging of the dsDNA genome by the small (gp40, TerS) and large (gp41, TerL) 
terminase subunits, resulting in a mature capsid (Spilman et al., 2011). Following capsid 
maturation, the non-contractile tail attaches to the capsid via gp42 resulting in a mature, 
viable virion.  
However, instead of one possible outcome, the mature viable phage virion, there 
is a second route of capsid assembly possible. Phage 80α also serves as a “helper” 
phage that aids in the mobilization of several SaPIs. SaPIs are a class of MGEs, roughly 
14-27 kb in size, that stably integrate into the host chromosome and often carry antibiotic 
resistance and toxin genes (Novick et al., 2010). SaPIs are considered molecular pirates 
because they package their own genomes into transducing particles comprised of helper 
phage-encoded proteins. One striking feature of this appropriation of the helper phage by 
a SaPI is redirection of the capsid assembly process to construct T=4 capsids with one-
third the volume of the mature 80α capsid (Christie et al., 2012). This difference in capsid 
size directly parallels the disparity between the genome sizes of 80α (~44 kb) and the 
prototypical pathogenicity island used in this work, SaPI1 (~15 kb). While SaPI1 can 
package its genome into either a small or large capsid, 80α is unable to package its 
complete genome into the smaller SaPI1 transducing particle. Furthermore, SaPI1 
preferentially packages its own genome using a SaPI1-encoded small terminase subunit 
(Ubeda et al., 2009). This results in interference with helper phage propagation and the 
efficient assembly of SaPI1 transducing particles from the phage structural proteins 
(Figure 2).  
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Figure 2: Model for high frequency SaPI1 transduction 
Following phage infection or the induction of a lysogenic prophage, SaPI1 excises from the S. aureus chromosome, re-
circularizes and begins replicating, packaging its DNA preferentially in small capsids. Upon lysis, progeny phage and SaPI1 
transducing particles are released, and are able to propagate throughout S. aureus, infecting naïve cells.  
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SaPI1 mobilization via helper phage 80α  
Upon infection by 80α or the induction of an 80α prophage from the host cell 
chromosome by the SOS response, a phage-encoded anti-repressor, Sri inhibits the 
SaPI1 repressor, Stl (Tormo-Mas et al., 2010). The SOS response is a global cellular 
response that is activated when DNA damage is so widespread that normal DNA repair 
mechanisms are ineffective (Willey, 2014). This derepression results in expression of 
SaPI1 genes leading to excision of SaPI1 from the host chromosome and its subsequent 
replication. With such a small genome, it is not surprising that SaPIs rely heavily on 80α 
for transducing particle assembly. Due to this ability to redirect capsid assembly, there is 
usually a one-hundred fold reduction in phage titer when there is also a SaPI present in 
the host cell. The completed SaPI1 transducing particles are now able to infect other 
naïve host cells upon lysis, potentially transferring virulence or toxin genes to the 
surrounding bacterial population (Figure 2).  
 
Phage 80α capsid assembly and its interaction with alternative scaffolds 
Capsid assembly is an essential process in the formation of mature 80α virions 
and SaPI1 transducing particles. As previously discussed, phage 80α capsid assembly 
begins with the gp46 scaffold acting as a chaperone protein for gp47 (Dokland, 1999). 
The 80α procapsid is formed from multiple copies of gp46, gp47, the portal protein gp42, 
and the minor capsid protein gp44. Prior to, or concurrently with procapsid expansion and 
DNA packaging, the gp46 scaffolding proteins are lost. In the presence of SaPI1, the 80α 
capsid protein gp47 interacts with the SaPI1-encoded alternate scaffold, CpmB or gp6 
(Dearborn et al., 2011). A second SaPI encoded gene, cpmA or gp7, is also involved in 
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forming small capsids, but its role is not well understood. The internal structures of 80α 
and SaPI1 procapsids are significantly different. Cryo-EM reconstructions of the 
procapsids revealed finger-like projections that extend towards the center of the 
procapsid of SaPI1 which were completely absent in 80α. Previous studies have shown 
that these finger-like densities are consistent with CpmB, the alternate scaffold protein, 
which forms a scaffold-like dimer that then associates with phage capsid (Dearborn et al., 
2011). The interaction between 80α capsid with two alternative scaffolds, the native 
phage scaffold protein and the alternate scaffold produced by SaPI1, is a unique feature 
of the system.  
The specific interactions between capsid and these two different scaffolding 
proteins are not well understood at this time. Previous work in our lab suggests that the 
C-terminus of SaPI1 scaffold is involved in the interaction with the phage capsid protein 
(E.A. Wall, unpublished). Similarities between the C-terminus of the phage and SaPI1 
scaffold proteins suggest that both scaffold proteins interact with major capsid protein 
gp47 in a similar manner. 
 The goal of this study was to investigate the residues involved in the 80α 
scaffold:capsid interface and determine whether these interactions were shared with the 
phage capsid and SaPI1 scaffold. Secondly, the role of N-terminal proteolytic cleavage 
of gp46 and gp47 in assembly of phage capsids and SaPI1 transducing particles was 
explored.  
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Chapter 2 
 Materials and Methods 
 
Note: All reagents used in this work were acquired through major suppliers including 
Fisher Scientific (Waltham, MA), and Sigma-Aldrich (St. Louis, MO), unless indicated 
otherwise.  
 
2.1 Bacterial Culture 
 All bacterial strains used in this work are listed in Table 1. S. aureus cultures were 
grown overnight in Luria-Bertani (LB) broth (Fisher Scientific, Waltham, MA), or Tryptic 
Soy Broth (TSB) (Fisher Scientific, Waltham, MA). All broth cultures were incubated at 
37°C on an orbital shaker at 200 rpm. S. aureus cultures were also grown on LB agar 
plates (1.8% agarose) and Tryptic Soy Agar (TSA) plates (1.8% agarose) and incubated 
overnight at 30°C. When necessary, the media was supplemented with erythromycin (5 
µg/ml). S. aureus strains carrying 80α prophage were plated on beta-glycerophosphate 
disodium salt pentahydrate (GL) agar (Novick, 1991) and incubated overnight at 30°C. 
 Escherichia coli strains were incubated overnight at 37°C on either LB or TSA plates, 
in addition to being grown in LB broth or TSB. Media for use with E. coli strains was 
supplemented with ampicillin (100 µg/ml) when needed.  
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Table 1: Bacterial strains used in this study 
S. aureus 
Strains 
Background Integrated Prophage/SaPI Reference 
RN4220 4220 None 
Kreiswirth, B.N., et 
al., 1983. 
RN10616 4220 80α 
Ubeda, C., et al., 
2009. 
RN10628 4220 80α SaPI1 tst::tetM 
Ubeda, C., et al., 
2009. 
ST91 4220 80α ∆gp46 Lab strain 
ST247 4220 80α gp46 ∆2-13 Lab strain 
ST248 4220 80α ∆gp47 Lab strain 
ST278 4220 80α gp46 R202S Lab strain 
ST279 4220 80α gp46 R202E Lab strain 
ST358 4220 80α gp46 I203T This study 
ST361 4220 80α gp47 F14A This study 
ST365 4220 ST247 + SaPI1 This study 
ST366 4220 ST278 + SaPI1 This study 
ST367 4220 ST279 + SaPI1 This study 
ST368 4220 ST358 + SaPI1 This study 
ST375 4220 80α gp47 E50R This study 
ST376 4220 80α gp47 E53R This study 
ST377 4220 80α gp46 R202E + gp47 E50R This study 
ST378 4220 80α gp46 R202E + gp47 E53R This study 
E. coli Strain Description Source 
Stellar™ 
Competent Cells 
HST08 derivative, high transformation 
efficiency strain. E. coli F–, endA1, supE44, thi-
1, recA1, relA1, gyrA96, phoA, Φ80d 
lacZΔM15, Δ(lacZYA-argF)U169, Δ(mrr-
hsdRMS-mcrBC), ΔmcrA, λ– 
Clontech 
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2.2 DNA Manipulations: Plasmid Construction  
 
 All plasmids used or created for this work are listed in Table 2. Restriction 
endonucleases, restriction enzyme buffers, and bovine serum albumin (BSA) used for 
DNA manipulations were purchased from New England Biolabs (Ipswich, MA) and were 
used in accordance with the manufacturer’s instructions. Restriction digests were 
performed in a volume of 25 µl, or multiples thereof, depending upon the downstream 
application(s) of the DNA product(s). Plasmid construction was accomplished through 
polymerase chain reaction (PCR) amplification of the desired insert, vector preparation 
(including PCR purification, restriction enzyme digestion, and gel extraction), In-Fusion 
reaction and finally confirmation of the construct through Sanger sequencing. Plasmid 
DNA preparations were performed using the QIAprep®Spin Miniprep Kit (Qiagen; 
Valencia, CA) in accordance with the manufacturer’s instructions. Plasmid DNA was 
eluted in warmed (65°C) HPLC-grade water for DNA sequencing. All PCR products were 
analyzed and/or prepared for PCR purification using agarose gel electrophoresis. PCR 
products were purified using the QIAquick PCR Purification Kit (Qiagen; Valencia, CA) 
and gel extractions were performed using the Nucleospin® Gel and PCR Clean-up Kit 
(Macherey-Nagel; Düren, Germany) in accordance with the manufacturer’s instructions. 
All DNA concentrations were determined using a Nanodrop 1000 spectrophotometer 
(Thermo Scientific; Waltham, MA). The Infusion® HD cloning kit (Clontech; Mountain 
View, CA), which utilizes the Gibson assembly method (Gibson, 2011), was used instead 
of an insert-vector ligation in accordance with the manufacturer’s instructions. All 
plasmids were verified by Sanger sequencing through Eurofins MWG Operon.  
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Table 2: Plasmids created or used for this this study 
Plasmid Description Reference 
pLAK1 pMAD derivative with 80α gp46 mutation I203T This study 
pLAK2 pMAD derivative with 80α gp47 mutation E50R This study 
pLAK3 pMAD derivative with 80α gp47 mutation E53R This study 
pLAK4 pMAD derivative with 80α gp46 mutation R202E and gp47 
mutation E50R 
 
This study 
pLAK5 pMAD derivative with 80α gp46 mutation R202E and gp47 
mutation E53R 
 
This study 
pMAD Shuttle vector used for allelic exchange in Gram-positive 
bacteria 
Arnaud et al., 
2004 
pMED2 pMAD derivative with 80α gp47 mutation F14A Lab Strain 
13 
 
 
2.3 Polymerase Chain Reaction (PCR) 
 
  PCR reactions were performed using a T-Gradient Thermoblock thermocycler 
(Biometra; Gottingen, Germany). Primers listed in Table 3 were obtained from Integrated 
DNA Technologies (Coralville, IA). The lyophilized primers were reconstituted with HPLC-
grade water to a final concentration of 1 mM. Primer working stock aliquots were prepared 
by 1:100 dilution with HPLC-grade water to 10 µM. All inserts were amplified using 
PfuUltra II Fusion HS DNA Polymerase (Agilent Technologies; Santa Clara, CA) in the 
following manner: 1x PfuUltra II reaction buffer (Agilent Technologies; Santa Clara, CA), 
100 µM dNTPs (Invitrogen; Grand Island, NY), 5-30 ng vector DNA input template, 0.2 
µM of both the forward and reverse primers, and 0.5 µl of PfuUltra II Fusion HS DNA 
polymerase, and brought to a final reaction volume of 50 µl. All PCR reaction master 
mixes were scaled up as needed with 10% excess to account for pipetting error. The 
following PCR parameters were followed for targets <10 kb: initial denaturation for 2 
minutes at 95°C, followed by 34 cycles of denaturation for 20 seconds at 95°C, primer 
annealing for 15 seconds, and primer extension for 15 seconds per kb of target DNA at 
72°C. A final 3 minute primer extension step was performed at 72°C. All reactions were 
kept at 4°C following the final extension prior to being stored at -20°C. Annealing 
temperatures for each primer were optimized based on the melting temperature (Tm) of 
each primer, as shown in Table 3, and were generally the average Tm-5°C. 
Colony PCR was performed by preparing the DNA template as follows: 1 isogenic 
colony was picked and smeared in an even layer into a sterile PCR tube,
14 
 
Table 3: Primers used in this study 
 
Primer 
 
Sequence (5’-3’) 
 
Direction 
Tm 
(°C) 
DNA 
Template 
Plasmid Construction Primers 
pLAK1 
 
EAW5 
CGATGCATGCCATGG*TGGTCGAAAA
CAAGGACTTTAGCGATAG 
 
F 
 
58.6 
 
RN10616 
 
EAW159 
TTTAAT(CG)TTCTTTT*TTGTCTAGCTA
TTTCAGCTAAGTTTTGCG 
 
R 
 
59.3 
 
RN10616 
 
EAW8 
GGCGATATCGGATCC*TTCCAATGAT
TTCGGGCATGTTAC 
 
R 
 
56.0 
 
RN10616 
 
EAW160 
AAAAGAA(CG)ATTAAA*AATTAACGGA
GGCATTTAAATGGAACAAAC 
 
F 
 
57.6 
 
RN10616 
pLAK2 
EAW58 
CGATGCATGCCATGG*TTAATAGCTA
GCACTTAATTGTGTTGGC 
 
F 
 
55.8 
 
RN10616 
EAW171 
CATAAC(ACG)TTGTAA*GATGGGCGT
TGTGAATTCATTC 
 
R 
 
57.9 
 
RN10616 
EAW61 
GGCGATATCGGATCC*ATATCTCAAA
AGAACACAGCCCTTCC 
 
R 
 
57.0 
 
RN10616 
EAW172 
TTACAA(CGT)GTTATG*GAAAACTCTA
AAATTATGCAATTAGGTAAGTACG 
 
F 
 
57.9 
 
RN10616 
pLAK3 
EAW58 
CGATGCATGCCATGG*TTAATAGCTA
GCACTTAATTGTGTTGGC 
 
F 
 
55.8 
 
RN10616 
EAW173 
AGAGTT(ACG)CATAAC*CTCTTGTAAG
ATGGGCGTTG 
 
R 
 
59.3 
 
RN10616 
EAW61 
GGCGATATCGGATCC*ATATCTCAAA
AGAACACAGCCCTTCC 
 
R 
 
57.0 
 
RN10616 
EAW174 
GTTATG(CGT)AACTCT*AAAATTATGC
AATTAGGTAAGTACGAACC 
 
F 
 
57.2 
 
RN10616 
pLAK4 
EAW58 
CGATGCATGCCATGG*TTAATAGCTA
GCACTTAATTGTGTTGGC 
 
F 
 
55.8 
 
ST279 
EAW171 
CATAAC(ACG)TTGTAA*GATGGGCGT
TGTGAATTCATTC 
 
R 
 
57.9 
 
ST279 
EAW61 
GGCGATATCGGATCC*ATATCTCAAA
AGAACACAGCCCTTCC 
 
R 
 
57.0 
 
ST279 
EAW172 
TTACAA(CGT)GTTATG*GAAAACTCTA
AAATTATGCAATTAGGTAAGTACG 
 
F 
 
57.9 
 
ST279 
pLAK5 
EAW58 
CGATGCATGCCATGG*TTAATAGCTA
GCACTTAATTGTGTTGGC 
 
F 
 
55.8 
 
ST279 
EAW173 
AGAGTT(ACG)CATAAC*CTCTTGTAAG
ATGGGCGTTG 
 
R 
 
59.3 
 
ST279 
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Table 3 (continued): Primers used in this study 
 
Primer 
 
Sequence (5’-3’) 
 
Direction 
Tm 
(°C) 
DNA 
Template 
Plasmid Construction Primers 
pLAK5 
EAW61 
GGCGATATCGGATCC*ATATCTCAAA
AGAACACAGCCCTTCC 
 
R 
 
57.0 
 
ST279 
EAW174 
GTTATG(CGT)AACTCT*AAAATTATGC
AATTAGGTAAGTACGAACC 
 
F 
 
57.2 
 
ST279 
Sequencing primers 
 
Primer 
 
Sequence (5’-3’) 
 
Direction 
Tm 
(°C) 
Template 
pLAK1 
EAW1 GTCGTTCAGATTGCGCTTTACTACC F 57.9 pLAK1 
EAW26 AGTTGATTCATCAGATGAGGTTGTC F 54.9 pLAK1 
PKD101 
GGTAGCTAGCAGACTATAAATGGAG
GTATATCTCATGGAAG 
F 56.1 pLAK1 
pMADSF 
CTAGCTAATGTTACGTTACACATTAAC
TAG AC 
F 55.3 pLAK1 
pMADSR CCCTGATGGTCGTCATCTACCTG R 58.7 pLAK1 
pLAK2/pLAK3/pLAK4/pLAK5 
EAW1 GTCGTTCAGATTGCGCTTTACTACC F 57.9 
pLAK2/pLAK3
pLAK4/pLAK5 
EAW24 ACG AAG ATG GCA CAC CTG F 55.2 
pLAK2/pLAK3
pLAK4/pLAK5 
EAW26 AGTTGATTCATCAGATGAGGTTGTC F 54.9 
pLAK2/pLAK3
pLAK4/pLAK5 
EAW172 
TTACAA(CGT)GTTATG*GAAAACTCTA
AAATTATGCAATTAGGTAAGTACG 
 
F 
 
57.9 
pLAK2/pLAK3
pLAK4/pLAK5 
SMT46 AAAAGGAAGGGCTGTGTTC F 57.0 
pLAK2/pLAK3
pLAK4/pLAK5 
ST247 
EAW6 
AATAATT(T)TTTTTTG*TCTAGCTATTT
CAGCTAAGTTTTGCG 
R 58.1 ST247 
EAW7 
CAAAAAA(A)AATTATT*AAAAATTAAC
GGAGGCATTTAAATGGAAC 
F 56.1 ST247 
EAW24 ACG AAG ATG GCA CAC CTG F 55.2 ST247 
ST361 
EAW24 ACG AAG ATG GCA CAC CTG F 55.2 ST361 
GC47FA3 
TGCGAGTAACAATGTTAAACCGCAAG
T 
F 59.2 ST361 
PKD47 
AGAATGAGTTAAAGCGAGATGTGAAA
AGCGGTGATTGATTTAAAAGTAAAGT
TT 
F 57.3 ST361 
Annealing sequence is underlined. Tm corresponds to annealing sequence. 
Restriction cuts marked with asterisk. Mutations in parentheses (XXX). 
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microwaved, cap open, on “High” for 90 seconds, and thoroughly vortexed with 10 µl of 
HPLC grade water. 
 
 
2.4 Agarose Gel Electrophoresis 
 
 Analytical and preparatory agarose gels were prepared to assess if PCR reactions 
were successful, prepare enzymatic restriction digests for gel purification, and to verify 
insertions or deletions of gene products in vectors. 0.6% and 1% agarose (KSE Scientific; 
Durham, NC) gels were prepared with 1X Tris-acetate-EDTA (TAE) buffer and 0.3 µg/ml 
ethidium bromide.  
 Samples for analytical gels were prepared in the following manner: 1 µl of 6X 
loading dye (50% v/v glycerol, 50% v/v 1X TAE, bromophenol blue added to desired color) 
was thoroughly mixed with 2 µl of the appropriate ladder, either Hyperladder I or 
Hyperladder IV (both supplied by Bioline; Taunton, MA). 1 µl of 6X loading dye was 
thoroughly mixed with 2 µl of sample to be analyzed and loaded into 1% agarose gels 
and electrophoresed in 1X TAE buffer at 115V for approximately 50 minutes, or until 
ladder bands were easily visualized.  
 Samples for preparatory gels were prepared in the following manner: 1 µl of 6X 
loading dye was thoroughly mixed with 2 µl of the appropriate ladder, either Hyperladder 
I or Hyperladder IV. For larger volumes, the loading dye was scaled up as follows: 25 µl 
6X loading dye was added to 150 µl PCR reactions or enzymatic restriction digests. For 
gel purifications, the entire sample plus the appropriate amount of loading dye was loaded 
into a single, large lane on the gel and electrophoresed in 1X TAE at 115V until ladder 
bands were easily visualized.  
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 Following electrophoresis, all gels were examined on a White/UV transilluminator 
(VWR; Randor, PA) and photographed using a Fotodyne FOTO/Analyst Apprentice - UV 
system (Heartland, WI) with a Canon Powershot S100 (Melville, NY) camera. Gel images 
were edited using Adobe Photoshop in a standardized manner: all gels were converted 
to grayscale and the auto-levels feature was used, without any additional manipulation, 
as needed.   
 
2.5 Construction of Plasmids 
 Plasmids were constructed through PCR amplification of the desired insert, vector 
preparation (including PCR purification, restriction enzyme digestion, and gel extraction), 
In-Fusion® reaction and final confirmation of the construct through Sanger sequencing. 
In-Fusion® reactions were generally performed as follows: ~60 ng of restriction enzyme 
digested vector, no less than 20 ng of insert DNA, and 2 µl of 5X In-Fusion® HD Enzyme 
Premix were brought to a final reaction volume of 10 µl with HPLC-grade water. The 
reaction mixture was incubated in a 50°C water-bath for 15 minutes and then placed on 
ice. The reaction was either stored at -20°C or used to transform competent cells. Vector 
control reactions were performed side-by-side, without the addition of the desired insert 
DNA.  
 
2.6 Transformation of E. coli 
 In order to propagate newly constructed plasmids, Stellar™ competent E. coli cells 
(Clontech Laboratories Inc., Mountain View, CA) were transformed with the plasmids. 
One 50 µl aliquot of competent cells was thawed on ice before being pipetted into a sterile 
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15 ml conical tube containing 2.5 µl of the final In-Fusion® reaction mixture. The reaction 
mixture was incubated on ice for 30 minutes before being heat-shocked in a 42°C water-
bath for 45 seconds and immediately placed on ice. After 2 minutes, 450 µl of SOC 
medium (Clontech Inc.; Mountainview, CA) was added to the reaction and it was then 
incubated for 1 hour at 37°C on an orbital shaker set to 200 rpm. After the hour long 
incubation, 5 µl and 100 µl of the transformation mixture were spread onto LB plates 
supplemented with 100 µg/ml ampicillin. The remaining volume of the transformation was 
aseptically transferred to a sterile 1.5 ml microcentrifuge tube and pelleted for 3.5 minutes 
at 4000 rpm. The supernatant was decanted and the pellet was re-suspended in the 
residual media by vortexing and the concentrate was also plated on the appropriate 
media. The vector control In-Fusion® reaction transformation was performed side-by-side 
and 100 µl of the transformation reaction was plated. All plates were incubated at 37°C 
for 24 hours.  
 
 
2.7 S. aureus Competent Cell Preparation (Nickoloff, 1995) 
 
 To prepare electrocompetent S. aureus cells, the desired strain was first grown 
overnight in TSB at 37°C with 200 rpm shaking. In a sterile Klett flask, 100 ml of fresh 
TSB was inoculated with 1 ml of the desired strain overnight culture. The culture was 
shaken at 37°C with 200 rpm shaking for approximately 3 hours, until Klett=95 
(OD600=0.5) was reached. The Klett flask was immediately transferred to ice for 15 
minutes to suspend bacterial growth. The culture was split between two 50 ml conical 
tubes, kept on ice at all times, and both were pelleted at 4°C for 15 minutes at 4000 rpm. 
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The supernatant was decanted and each cell pellet was re-suspended and washed with 
15 ml ice-cold, sterile Milli-Q (EMD Millipore; Darmstadt, Germany) water before being 
re-pelleted at 4°C for 15 minutes at 4000 rpm. The wash step was repeated 2 more times 
for a total of 3 wash steps. Each cell pellet was then washed with 30 ml ice-cold sterile 
10% glycerol and allowed to sit at room temperature for 15 minutes. The cells were 
pelleted at 4°C for 5 minutes at 4000 rpm and the supernatant was decanted. Each pellet 
was re-suspended in 300 µl of 10% ice-cold glycerol. The re-suspended cells were 
aliquoted (60 µl) and stored at -80°C.  
 
 
 
2.8 Transformation of S. aureus  
 
S. aureus electrocompetent cells (all RN4220 derivatives) were transformed by 
electroporation. One 60 µl aliquot of the desired electrocompetent cells was thawed on 
ice and 6 µl (0.3-0.6 µg) plasmid DNA were added to the thawed cells and allowed to sit 
for 30 minutes on ice. Pipette tips and cuvettes were kept at -20°C prior to being used. 
The reaction mixture was transferred to a 0.1 cm Gene Pulser® cuvette and 
electroporated on the STA setting (2.50 kV for 1 pulse, 2.5 ms) of a MicroPulser™ 
electroporation apparatus. Immediately after the pulse, 0.7 ml of brain heart infusion broth 
(BHI) was added directly to the cuvette and the cells were transferred to a 2 ml 
microcentrifuge tube containing an additional 0.3 ml BHI. Cells recovered by shaking at 
32°C and 200 rpm for 2 hours. Cells were plated on TSA plates supplemented with 
appropriate antibiotics and/or X-gal, as needed. Generally, 5 µl, 100 µl and the cell pellet 
concentrate (pelleted at 4000 rpm for 3 minutes, supernatant decanted, pellet re-
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suspended in residual supernatant) were spread and incubated for 48 hours at 32°C.  
 
2.9 Allelic Exchange 
  
S. aureus strains carrying derivatives of the pMAD allelic exchange vector were 
selected by plating on TSA plates supplemented with erythromycin (5 µg/ml) and X-gal 
(200 µg/ml) and incubated overnight at a permissive growth temperature, 32°C. Blue 
candidate colonies were chosen. TSB (2 ml) supplemented with erythromycin (5 µg/ml) 
was inoculated with a single colony and shaken overnight in a 42°C water-bath, which is 
a non-permissive growth temperature for the pMAD plasmid. Selection for antibiotic 
resistance at this temperature yields cells in which there has been homologous 
recombination of the plasmid carrying the desired mutation into the gene of interest in the 
S. aureus chromosome, yielding a cointegrate. All experiments were performed in 
quadruplicate. Samples were subcultured into 2 ml fresh TSB supplemented with 
erythromycin (5 µg/ml) and shaken overnight in a 42°C water-bath. This step was 
repeated a third time. The cultures were then 10-fold serially diluted to 10-5 and 100 µl 
were spread on TSA plates supplemented with erythromycin (5 µg/ml) and X-gal (200 
µg/ml) and incubated overnight at 42°C. Blue cointegrate colonies were chosen. TSB (5 
ml) was inoculated with one blue colony and shaken overnight at 200 rpm at 30°C, a 
permissive temperature that encourages plasmid resolution. This step was repeated 
before samples were subcultured into 2 ml fresh TSB and shaken overnight at 42°C. This 
step was repeated twice. The cultures were 10-fold serially diluted to 10-5 and 100 µl was 
spread on TSA plates supplemented with X-gal (200 µg/ml). Plates were incubated for 48 
hours at 30°C. White colonies were patched onto TSA plates supplemented with 
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erythromycin (5 µg/ml) and X-gal (200 µg/ml) and onto TSA plates supplemented with 
only X-gal (200 µg/ml), in that order. Plates were incubated overnight at 30°C. White 
erythromycin-sensitive candidate colonies/patches that resolved the cointegrate and the 
plasmid were picked and plated on TSA plates supplemented with X-gal (200 µg/ml). 
Plates were incubated for 24-48 hours at 30°C. Candidate colonies were screened via 
colony PCR to ensure that the desired insert had homologously recombined and resolved 
and that the isolated candidate colony was not carrying an empty vector. After PCR 
screening, PCR clean-ups were performed using the QIAquick PCR Purification Kit 
(Qiagen; Valencia, CA), and allelic exchange candidates were verified by Sanger 
sequencing through Eurofins MWG Operon.  
 
 
2.10 Phage Propagation: Inductions 
 
 Lysogenic staphylococcal strains were induced in order to generate bacteriophage 
80α phage lysates. Inductions were performed either through UV irradiation or the use of 
mitomycin C (MC). Both methods take advantage of the SOS response pathway which 
occurs in direct response to cellular DNA damage. Ten milliliters of a 25:1 solution of CY 
+ GL media were inoculated with 50-100 µl of fresh overnight culture of the desired 
lysogenic S. aureus strain. CY media is a preparation of 1% wt/vol casamino acids, 1% 
wt/vol yeast extract, 0.5% wt/vol glucose, 0.59% wt/vol NaCl (Novick, 1991). GL media is 
composed of 0.6 M β-glycerophasphate disodium salt pentrahydrate. Cell density was 
measured using a Klett-Summerson colorimeter until the starting cell density was 
approximately 10% of the final desired cell density. Cultures were grown at 30°C with 200 
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rpm shaking and cell density was monitored for several hours until the appropriate cell 
density was reached. For induction by UV irradiation, the final cell density was 
approximately Klett=95 or OD600=0.6, while cultures for MC induction were grown to 
Klett=30 or OD600=0.3. 
 For MC induction, equal volumes of SA phage buffer (Novick, 1991) (1 mM MgSO4, 
4 mM CaCl2, 2.5 M Tris-HCl pH 7.8, 100 mM NaCl, 0.1% gelatin) and CY + GL media 
were combined. One milliliter of the Klett=100 culture was added to 9 ml CY + GL/ SA 
phage buffer. Two microgram per milliliter of MC was added to the culture mixture and 
then grown at 30°C with reduced shaking, 100 rpm, for approximately 2 hours or until cell 
lysis. Lysates were filter sterilized using a 0.22 µm syringe filter and stored at 4°C.  
 For UV induction, cultures were grown to Klett=30. Cultures were aseptically 
transferred to 15 ml conical tubes and centrifuged for 10 minutes at 4000 rpm at 4°C. The 
supernatant was discarded and the pellet was re-suspended in 5 ml of SA phage buffer. 
A conical tube containing 5 ml CY + GL buffer was prepared and set aside. The re-
suspended cell pellet was transferred to a sterile petri dish, avoiding bubble formation. In 
a Nuaire Biological Safety Cabinet - Class II, Type A/B, equipped with a Philips TUV 
15W/G15 Longlife bulb, the petri dish was placed on a rocker, the lid removed, and 
exposed to UV light for 20 seconds. The distance from the plate rocker to the UV bulb 
was approximately 57.8 cm. The prepared 5 ml CY + GL media was added immediately 
to the petri dish. The petri dish contents were transferred to a new, sterile Klett flask and 
incubated at 30°C with reduced shaking, 100 rpm, for approximately 2 hours or until cell 
lysis. Lysates were filter sterilized using a 0.22 µm syringe filter (Millipore; Billerica, MA) 
and stored at 4°C.  
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2.11 Bacteriophage Titering Assay 
All titering assays were performed in triplicate. Five milliliter cultures of S. aureus 
RN4220 were grown overnight at 37°C in TSB with 200 rpm orbital shaking. Lysate 
dilutions were prepared as follows for both the control strain (RN10616) and the strain to 
be tested: 10-2, 10-3, 10-4, 10-6, 10-7, and 10-8 dilutions of phage lysate in SA phage buffer. 
One hundred-fold dilutions were made by diluting 10 µl of lysate into 990 µl SA phage 
buffer. Ten-fold dilutions were made by diluting 100 µl of lysate into 900 µl SA phage 
buffer.   
 Top agar aliquots were prepared by mixing 3 ml of top agar with 30 µl of 0.5 M 
CaCl2 (final concentration of 5 mM) and incubating at 65°C immediately prior to use. 
Phage top agar is composed of 0.3% wt/vol casamino acids, 0.3% wt/vol yeast extract, 
100 mM NaCl, 0.75% wt/vol agar, pH 7.8 (Novick, 1991). One hundred microliters of the 
phage lysate dilution was mixed with 100 µl of the RN4220 overnight culture and allowed 
to adsorb for 3 minutes at room temperature. After adsorption, the top agar mixture was 
added to the 200 µl phage:RN4220 mixture and immediately poured onto phage agar 
plates and allowed to solidify at room temperature. Phage agar plates are composed of 
0.3% wt/vol casamino acids, 0.3% wt/vol yeast extract, 100 mM NaCl, 1.5% wt/vol agar, 
pH 7.8 with 5 mM CaCl2 added after media was autoclaved (Novick, 1991). Phage agar 
plates were incubated at 32°C for 24 hours before plaques were counted. Plaque forming 
units were calculated using the following equation: 
 
PFU
ml
=
number of plaques
(d x v)
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Where,   d = dilution of plate counted 
    v = volume of lysate dilution plated  
 
 
2.12 SaPI1 Transductant Titering Assay 
 The quantification of SaPI1 transductants was accomplished through a modified 
phage-titer protocol, as described above. All SaPI derivatives used in this study contain 
a tetM cassette. As a result, SaPI1 strains were selected by plating on GL plates 
supplemented with 5 µg/ml tetracycline. Serial dilutions were made following the phage-
titer assay protocol: 100 µl of lysate dilution was mixed with 100 µl of RN4220 culture and 
allowed to adsorb at room temperature for 5 minutes. The 200 µl lysate dilution:RN4220 
mixture was poured onto GL-tet plates and allowed to solidify at room temperature before 
being incubated for 24-48 hours at 32°C. SaPI1 colonies or transducing units (TU) were 
calculated using the following equation: 
 
TU
ml
=
number of plaques
(d x v)
 
 
Where,   d = dilution of plate counted 
    v = volume of lysate dilution plated  
 
 
2.13 Plaque Purification Assay 
 In order to isolate plaques for further analysis, individual plaques were cored from 
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the titer plates using a flame sterilized Pasteur pipette and expelled into a 1.5 ml 
microcentrifuge tube containing 1 ml of SA phage buffer. The agar core was allowed to 
stand at room temperature for 15 minutes before being serially diluted as follows: 100,  
10-1, 10-2, 10-3 and 10-4. Dilutions were prepared and plated, following the standard phage 
titering assay: 3 ml of top agar, supplemented with 30 µl of 0.5 M CaCl2, were prepared 
and kept at 65°C prior to use. One-hundred microliters of an overnight culture of RN4220 
were mixed with 100 µl of each lysate dilution and the phage were allowed to adsorb for 
3 minutes at room temperature. The supplemented top agar was added to the phage 
dilution-cell mixture and immediately plated on phage agar. Plates were allowed to solidify 
at room temperature before being incubated for 24 hours at 32°C. Purified plaques were 
then cored and expelled into 1 ml HPLC-grade water. One microliter was used as the 
template to perform PCR amplifications of the mutant strain in order to confirm the 
mutation through Sanger sequencing.  
 
2.14 Data Analysis 
 All titer assay data were analyzed in GraphPad Prism® (La Jolla, CA). Raw data 
were organized in Microsoft® Excel® 2013 (Redmond, WA) and phage titers were 
calculated in PFU/ml. The phage titers were then imported into GraphPad Prism® and 
graphed. Phage titer assays were performed in biological and technical triplicate and all 
significant results were averaged and standard deviation was calculated.  
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Chapter 3 
 
Investigation of the interface between 80α scaffold and major capsid proteins 
 
 
 
Introduction 
 
Bacteriophage virion assembly begins with the formation of a transient procapsid, 
which eventually expands to form a mature virion. Procapsid assembly is important 
because without a properly formed procapsid, the subsequent capsid assembly steps will 
not occur, preventing the formation of viable phage progeny. The procapsid is an empty 
precursor particle that is comprised primarily of scaffold and capsid proteins. In addition, 
a portal protein and an uncharacterized minor capsid protein are involved in 80α 
procapsid assembly. Scaffolding proteins act as a catalyst for procapsid formation by 
serving as molecular chaperones for the major capsid protein, leading to the nucleation 
of the major capsid proteins and eventual procapsid formation (Dokland, 1999). While this 
protein:protein interaction is critical to capsid assembly, little is known about the specific 
way in which 80α scaffold and capsid interact. In the case of 80α, the major capsid protein 
also interacts with the SaPI1-encoded alternative scaffolding protein, CpmB. These two 
capsid assembly pathways provide a unique model for the study of scaffold:capsid 
interaction.  
The likely contacts between SaPI1 scaffold CpmB and 80α capsid protein gp47 
were mapped by a previous genetic study carried out in our lab.  The two SaP1-encoded  
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capsid size redirection genes, cpmA and cpmB, were introduced into the capsid 
morphogenesis gene cluster of an 80α prophage between gp44 (minor capsid protein) 
and gp46 (scaffold). This was lethal to lytic growth of the phage, because only small 
capsids that are unable to accommodate the larger phage genome were formed. This 
provided a strong selection for lthe oss of ability to form small capsids, as such mutants 
would restore phage growth.  Rare viable phage plaques were isolated that restored the 
ability to form large capsids (E.A. Wall, unpublished). These mutants either carried 
deletions of cpmA and cpmB or point mutations in cpmB.  Those in cpmB mapped to two 
regions, one being the dimer interface and the other being the very C-terminal end of the 
protein (Figure 3).  While the SaPI1 scaffold and 80α scaffold proteins are very different 
in size and share little overall amino acid similarity, there is a striking conservation of 
residues at their C-termini, particularly the RIIK motif where the cpmB mutations were 
found. This suggested that both scaffolds are interacting with the phage capsid protein in 
a similar way, likely involving the same region of capsid. Two questions were posed based 
on these results: (1) will these C-terminal scaffold mutations found in SaPI1 have the 
same effect if they are introduced into the 80α scaffold protein? (2) Can we use these 
mutations in scaffold to isolate compensatory capsid mutations that would help identify 
where and how gp46 interacts with gp47? 
 
Compensatory 80α capsid mutations 
The C-terminal point mutations that prevented small capsid formation in SaPI1 
CpmB were R69S, R69K, and I70T (Figure 3; E.A. Wall, unpublished). Our strategy was 
to introduce similar mutations into the C-terminus of phage scaffold and then try to isolate  
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Figure 3: Alignment of the C-termini of SaPI1 CpmB and 80α gp46 
 
Four C-terminal residues in the alternate SaPI1 scaffold protein, CpmB, and 80α scaffold 
protein, gp46, RIIK, are highly conserved. Not shown here are SaPI2 and SaPI3, which 
also contain conserved RIIK residues in their alternate scaffold proteins.  The red arrows 
indicate rare compensatory mutations found in CpmB, following the expression of CpmA 
and CpmB in 80α, and the corresponding mutations subsequently introduced into the C-
terminus of 80α scaffold.  
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spontaneous compensatory mutants in capsid. Because a single point mutation has a 1 
in 106 likelihood of occurring spontaneously, all of our mutations were made using 2 
nucleotide changes that would naturally occur at a rate of 1 in 1012. Since the standard 
80α lysate after prophage induction has a titer of approximately 1010 PFU/ml, 
spontaneous revertants of the change in scaffold should be well below the limit of 
detection. The arginine to lysine mutation was not used in this study as there is no lysine 
codon that can be substituted that cannot revert to arginine by a single nucleotide change. 
Instead, the arginine was replaced independently with a glutamic acid and a serine. The 
serine and glutamic acid point mutations were introduced into an 80α lysogen, resulting 
in R202S and R202E. It was predicted that the introduction of these point mutations into 
this highly conserved region of 80α scaffold protein would force compensatory mutations 
in capsid that would re-establish the scaffold-capsid interface and therefore allow the 
production of viable phage. When these mutations were introduced, R202E and R202S 
were both lethal to the phage, as expected, underscoring the importance of the highly 
conserved C-terminal region of scaffold.  
Unfortunately, neither point mutation at residue 202 in 80α scaffold generated any 
spontaneous compensatory mutations. We next examined the effect of mutations 
introduced at residue 203, equivalent to CpmB residue 70. The same I to T mutation that 
inactivated CpmB was introduced into 80α scaffold, resulting in a new 80α lysogen 
carrying gp46 I203T. Upon UV induction and plaque titering, viable plaques were 
recovered at a low frequency (Figure 4). After plaque purification, several mutant 
candidates were sequenced to determine the nature of the mutations. Three distinct 
compensatory mutations were found in 80α capsid: M52I, M52L, and Y123C.  
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Figure 4: Representative effect of gp46 I203T mutation on 80a phage titer. 
 
Wildtype 80α (RN10616) and 80α gp46 I203T (ST358) strains were grown to mid-
exponential phase before being induced with 2 µg/ml of mitomycin C. The I203T scaffold 
mutants that formed plaques also contained compensatory capsid mutations. 
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Effect of C-terminal scaffold mutations on SaPI1 
Although SaPI1 CpmB acts as an alternate scaffold, the phage scaffold protein is 
still required. We predicted that another part of the larger phage scaffolding protein 
provided this “other” function, and that the presence of SaPI1 scaffold would substitute 
for the phage scaffold RIIK capsid interaction during formation of small procapsids. 
Therefore, we examined the effects of C-terminal 80α scaffold mutations on SaPI1 
transduction. Three separate 80α lysogens containing mutations in the conserved C-
terminal residues of scaffold, specifically R202E, R202S, and I203T, were transduced 
with SaPI1. When the original 80α strains were induced and titered, as discussed above, 
all three resulted in a lethal phage phenotype. The strain encoding the I203T mutation in 
scaffold did result in the low level production of rare compensatory capsid mutations. The 
80α prophage in these SaPI1 transductions was induced, and both the phage and SaPI1 
titers were determined. No SaPI1 transducing particles were recovered from either of the 
point mutations at residue 202. However, when the strain carrying the I203T mutant was 
induced and titered, SaPI1 transduction appeared to be normal. While these are 
preliminary results, they are notable as they indicate the SaPI1 scaffold does not simply 
replace the C-terminal contacts made by the phage scaffolding protein. The different 
behavior of the R202 mutants and the I203T mutant in supporting SaPI1 growth is not 
currently understood.  
 
Identifying the specific scaffold and capsid interface 
Based upon a structural model of the SaPI1 scaffold CpmB mapped onto cryo-EM 
densities of the SaPI1 procapsid, (Dearborn et al., 2012), it appeared that an alpha-helix 
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of the C-terminal end of scaffold and an alpha-helix near the N-terminus of capsid formed 
a  parallel interface. The compensatory mutations M52I and M52L map to a residue within 
a predicted alpha-helix near the N-terminus of capsid. This residue is flanked by two 
glutamic acids at residues 50-53 (EVME). This led to the hypothesis that the conserved 
and critical C-terminal R202 residue in scaffold could interact with and possibly form a 
salt-bridge with one of the glutamic acid residues in 80α capsid (Figure 5). The protein 
stabilization created by the interaction of the guanidinium group of arginine and the side 
chain carboxyl of glutamic acid would contribute to maintenance of the proper alpha-
helical interaction between scaffold and capsid (Figure 6). Recently, Cortines et al. have 
shown that a specific salt-bridge interaction between the C-terminal scaffold residue R293 
and the N-terminal capsid residue D14 in bacteriophage P22 is enough to establish the 
proper protein:protein interaction for successful procapsid assembly.  
To test the hypothesis that R202 interacts with E50 or E53, four new strains 
containing 80α prophages with scaffold and capsid mutations were constructed: gp47 
E50R (ST375), gp47 E53R (ST376), gp46 R202E + gp47 E50R (ST377), and gp46 
R202E + gp47 E53R (ST378). The prediction was that at least one of the capsid 
mutations, E50R or E53R, would be lethal, due to the inability to form a salt bridge with 
R202. The R202E scaffold mutation, on its own, is lethal. However, if the salt-bridge 
interaction was occurring at the proposed residues, then it was anticipated that the 
simultaneous replacement of R with E in scaffold and E with R in capsid would lead to the 
re-establishment of the salt-bridge interaction and rescue the lethal R202E scaffold 
phenotype, resulting in viable progeny phage. All four strains were induced using MC, 
and plaque titer assays were performed. Surprisingly, both single capsid mutant strains,  
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Figure 5: Predicted secondary structure of the hypothesized alpha-helical interaction site between gp46 (scaffold 
protein) and gp47 (major capsid protein). 
 
The predicted secondary structures of gp46, scaffold protein, and gp47, major capsid protein. The PSIPRED v3.3 Protein 
Sequence Analysis Workbench was used to generate predicted secondary structure.  
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Figure 6: Schematic of the proposed salt-bridge interaction between R202 in gp46 
and either E50 or E53 in gp47.  
 
The non-covalent protein-protein interactions established by the salt-bridge between 
R202 and E50 or E53 may be enough to establish the proper helical interface for 
successful procapsid assembly.  
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ST375 and ST376, behaved like wild-type 80α, indicating that neither glutamic acid in 
capsid was essential or specifically interacting in a critical way with the arginine in scaffold 
(Figure 7).  Similarly, both of the double phage mutants remained non-viable (Figure 8). 
This indicates that the predicted salt bridge contact between R202 in phage scaffold, and 
either E50 or E53 in phage capsid, was incorrect. 
 
 
Discussion 
 Mutations in the C-terminal end of scaffold gave rise to compensatory mutations, 
M52I and M52L, within the predicted alpha-helix in phage capsid, indicating that this 
region of capsid does make contact with the scaffold C-terminus. However, the predicted 
salt bridge interaction involving one of the flanking glutamic acid residues was not ruled 
out by this study. The lethality of the R to K substitution in scaffold still argues strongly for 
a salt bridge interaction. Recent studies have indicated that single amino acid salt-bridge 
interactions are able to sustain proper protein:protein interaction for successful procapsid 
assembly in a similar way to our current model. The C-terminal domain of the P22 
scaffolding protein is alpha-helical, which is comparable to the predicted C-terminal alpha-
helix of the 80α scaffold protein. Again, similar to our model, the N-terminal alpha-helix of 
the major capsid protein of P22 is thought to interact with the N-terminal region of scaffold 
(Cortines et al. 2014). However, Cortines et al. also indicated other nearby amino acids 
that played a stabilizing role in the salt-bridge interaction between the major capsid 
protein and scaffold protein of P22, but were not essential. It seems likely, therefore, that 
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Figure 7: Effect of E50R and E53R gp47 major capsid protein mutations on 80α 
phage titer.  
 
Strains lysogenic for wild type 80α (RN10616), 80α gp47 E50R (ST375) and 80α gp47 
E53R (ST376) were grown to mid-exponential phase before being induced with 2 µg/ml 
of mitomycin C. Each bar is the result of 3 independent experiments, and the error bars 
indicate standard deviation.  
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Figure 8: Effect of E50R and E53R gp47 major capsid protein mutations paired with 
an R202E gp46 scaffold mutation on 80α phage titer.  
 
Strains lysogenic for wild-type 80α (RN10616), 80α R202E (ST279), 80α gp46 R202E + 
gp47 E50R (ST377), and 80α gp46 R202E + gp47 E53R (ST378) were grown to mid-
exponential phase before being induced with 2 µg/ml of mitomycin C. Each bar is the 
result of 3 independent experiments, and the error bars indicate standard deviation.  
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there is a salt bridge interaction involving a different E or D residue located near this helix 
in the 3-D structure of capsid that remains to be identified. 
Of note is the third compensatory capsid mutation that was isolated from the 
scaffold I203T mutant strain: Y123C. In 80α capsid, there is an integral proline at residue 
132 in the procapsid. This proline forms a kink in the α-helix and allows the structural 
rearrangement that accompanies a conformational switch necessary for expansion of the 
procapsid to the mature capsid (Spilman et al., 2011).  Based on an I-TASSER model of 
80α capsid mapped onto the HK97 fold, Y123 is predicted to be on the same alpha-helix 
as P132. At this time, the biological implications of this compensatory mutation have not 
been fully examined.   
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Chapter 4 
 
 
The role of N-terminal cleavage of scaffold and major capsid proteins in 
staphylococcal phage 80α and SaPI1 
 
 
Introduction 
Unlike other bacteriophages characterized to date, 80α does not encode a prohead 
protease, but rather uses a host-encoded protease for N-terminal cleavage of both its 
scaffold (gp46) and major capsid (gp47) proteins (Spilman et al., 2012). When the genes 
encoding gp46 and gp47 were cloned into an E. coli expression vector and expressed, 
neither protein was cleaved. However, when gp46 and gp47 were coexpressed in S. 
aureus, both proteins underwent proteolytic processing to a cleaved form (Spilman et al., 
2012), identical to those found in mature virions (Poliakov et al., 2008). The host-encoded 
protease responsible for the N-terminal cleavage of scaffold and capsid was recently 
identified as the phage-related ribosomal cysteine protease, Prp (Wall et al., 2015). Prp 
removes the first 13 amino acids from gp46 and the first 14 from gp47 by cleaving 
between phenylalanine and alanine in a conserved motif. Capsid cleavage apparently 
occurs even in the absence of capsid assembly. Therefore, we wanted to investigate the 
requirements for scaffold and capsid cleavage in the assembly of both phage and SaPI 
capsids.  
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N-terminal cleavage of scaffold 
 A mutant allele of the scaffold gene expressing the cleaved version of the protein 
 (accomplished by deletion of amino acids 2-13) was introduced into an 80α prophage 
through allelic exchange to generate strain ST247. The “precleaved” 80α (gp46∆2-13) 
lysogen was induced by UV irradiation and titered following the standard plaque assay. 
No viable phage were recovered (Figure 9).  
 Previous studies have demonstrated that scaffold is essential for formation of 80α 
capsids. Strain ST91, an 80α lysogen in which orf46 has been deleted, was induced, and 
the resulting lysate was purified and examined via electron microscopy (EM) (Spilman et 
al., 2012). Experiments replicating this result and comparing it to the structures 
assembled after induction of the pre-cleaved scaffold mutant in ST247 were performed 
by Keith Manning in Dr. Terje Dokland’s lab (Figure 10). As can be seen in Figure 10, 
both the complete deletion of gp46 and the pre-cleaved form of gp46 result in strikingly 
similar phenotypes. While the characteristic non-contractile tails and baseplates of 80α 
were observed, no procapsids or mature capsids were seen. This indicates that the 
cleavage of gp46 is essential and that improper regulation or timing of cleavage is as 
detrimental to 80α as the complete absence of scaffold.  
 
Effect of scaffold mutations on SaPI1 
 80α capsid is unique in its ability to interact with not only its own native phage 
scaffold, but also the alternate scaffold formed by SaPI1. However, the SaPI1-encoded 
alternate scaffold is unable to substitute completely for phage scaffold (Spilman et al., 
2012). Therefore, we wanted to examine the role of scaffold cleavage in formation of 
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Figure 9: Effect of N-terminally cleaved scaffold on 80α titer. 
Strains carrying prophage of wild-type 80α (RN10616) and 80α with N-terminally cleaved 
gp46 ∆2-13 (ST247) were grown to mid-exponential phase before being induced with 2 
µg/ml of mitomycin C, and the resulting lysates were titered on RN4220. Each bar is the 
result of 3 independent experiments, and the error bars indicate standard deviation.  
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Figure 10: Electron micrographs of CsCl purified 80α phage structures from 
scaffold mutants. 
 
EMs used with permission of Dr. Terje Dokland. Scale bar indicates 100 nm. Phage 
suspensions for negative stain were applied to glow-discharged carbon-only grids 
(Electron Microscopy Sciences), washed twice with dialysis buffer and stained with 1% 
uranyl acetate. Samples were observed in an FEI Tecnai F20 electron microscope 
operated at 200kV. Images were captured on a 4k x 4k Gatan Ultrascan CCD camera.  
 
(A) EM of structures formed by induction of an 80α lysogen encoding pre-cleaved scaffold 
(ST247).   
 
(B) EM of structures formed induction of an 80α lysogen encoding scaffold deletion 
(ST91). White arrows indicate possible portal structures, not procapsids.  
A 
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SapI1 transducing particles. SaPI tst:tetM was introduced by transduction into the strain 
carrying the 80α (gp46∆2-13) prophage to yield strain ST365. The resulting lysate was 
titered for SaPI1 transducing particles following UV induction. While this experiment has 
only been carried out once thus far and must be considered preliminary, SaPI1 was able 
to transduce effectively.  
Additionally, we wanted to examine the effects of C-terminal 80α scaffold 
mutations on SaPI1 transduction. In particular, we wanted to test whether the wild-type 
SaPI1 alternate scaffold could substitute for phage scaffold that was defective in the 
similar C-terminal contacts with capsid. SaPI1 was transduced into an 80α lysogen 
containing mutations in the conserved C-terminal residues of scaffold, specifically R202E, 
R202S, and I203T, resulting in the following strains: ST366 (80α gp46 R202S), ST367 
(80α gp46 R202E), and ST368 (80α gp46 I203T). As described in Chapter 3, all three of 
these mutations prevented 80α plaque formation, and the I203T mutation gave rise to 
rare compensatory capsid mutants. When the strains carrying mutant R202E and R202S 
prophages plus SaPI1, were induced and titered, no SaPI1 transducing particles were 
recovered. However, when the strain encoding the I203T mutant was induced and titered, 
SaPI1 transduction appeared to occur at wild-type levels. These results are notable as 
they indicate SaPI1 does not require the N-terminal cleavage of 80α scaffold to transduce 
effectively. However, C-terminal point mutations in 80α scaffold, specifically R202E and 
R202S, block SaPI1 transduction, demonstrating that SaPI1 does not simply replace the 
contacts between the scaffold C-terminus and the capsid N-terminus with its own scaffold-
capsid interaction. The difference between the results obtained with the R202 mutants 
and the I203T mutant remains to be explained.  
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Effect of uncleavable capsid on 80α growth 
The role of capsid cleavage in 80α was investigated by introducing the mutation 
F14A into the cleavage motif. This prevents cleavage of the capsid protein. This mutant 
allele was introduced into an 80α prophage and assayed for plaque formation following 
UV induction. Surprisingly, this mutation resulted in viable phage with a titer that was not 
significantly different from wild-type titer (Figure 11). While N-terminal cleavage of scaffold 
is essential for the production of viable phage virions, cleavage of the capsid protein is 
not essential for proper capsid formation.  
 The result with uncleavable capsid has been confirmed in a slightly different 
background, RN450. Our uncleavable capsid strain, ST361, was constructed in the strain 
RN4220. RN4220 is a restriction-minus derivative strain of RN450 (Novick, 1967; 
Kreiswirth et al. 1983). Strain ST208, which also contains a prophage with uncleavable 
capsid (gp47 F14A) is in the RN450 background. Figure 12 presents unpublished data 
from our collaborator’s lab of cryo-EM images obtained after the induction and purification 
of ST208 lysates. Both wild-type 80α and uncleavable capsid are strikingly similar in their 
mature capsid formation, providing further evidence that the cleavage of major capsid 
protein is not required for phage viability. Furthermore, 3-D reconstruction of the cryo-EM 
images display extra density on the outside of the capsids, attributable to the extended 
N-terminal residues (data not shown).  
 
Discussion 
These data indicate that the cleavage of gp46 during assembly is an essential 
process in the formation of phage capsids. It is hypothesized that the N-terminal tail of  
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Figure 11: Effect of uncleavable capsid protein, gp47, on 80α phage titer.  
 
Strain carrying lysogens of wild-type 80α (RN10616) and 80α gp47 F14A (ST361), 
uncleavable capsid protein, strains were grown to mid-exponential phase before being 
induced with 2 µg/ml of mitomycin C and titered on RN4220. Each bar is the result of 3 
independent experiments, and the error bars indicate standard deviation.  
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Figure 12: Cryo-EM of capsid formation in wild-type 80α (A) and uncleavable capsid 
(gp47 F14A) (B). 
 
EMs used with permission of Dr. Terje Dokland. Samples of purified phage lysate were 
applied to C-flat holey film (Electron Microscopy Sciences), flash frozen, transferred to a 
Gatan 626 cryo-specimen holder and visualized in an FEI Tecnai F20 electron 
microscope operated at 200 kV at a magnification of 81,200x.  
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scaffold may play a role in stabilization during procapsid formation, as scaffold serves as 
a chaperone for the proper accumulation of capsid, and therefore proper procapsid 
assembly. Without this interaction, no viable phage progeny are produced. However, this 
cleavage event is apparently not required for efficient SaPI1 transduction. SaPI1 
transduction by the 80α gp46∆2-13 prophage in ST247 remarkably resulted in viable 
transducing particles even though ST247 alone cannot produce viable phage. This 
suggests that a SaPI1 gene product, possibly the alternate scaffold, CpmB, can substitute 
for this particular function of phage scaffold. The respective roles of SaPI1 and phage 
scaffold proteins in assembly of SaPI transducing particles are still not well understood. 
Previous experiments determined that deletion of 80α gp46 resulted in both dead phage 
and no SaPI1 transducing particles, so SaPI1 is clearly dependent on phage scaffold in 
some way (Spilman et al., 2012).  
One hypothesis for the presence of viable SaPI1 transducing particles is that a 
virion structure is formed in the pre-cleaved scaffold mutant but it is unable to produce 
viable phage, possibly because it is unable to expand to mature capsid. In that case, the 
genome of 80α would not be packaged, but the smaller SaPI1 genome could still be 
accommodated. However, the EMs of ST247 do not reveal any procapsid formation, 
indicating that SaPI1 must be compensating in some way to allow capsid assembly, 
possibly via the alternative scaffold, CpmB. Additionally, if the N-terminus of phage 
scaffold is required for Prp binding and chaperone function, maybe SaPI1 CpmA can 
function as an alternative chaperone for assembly of the smaller SaPI1 procapsids. 
Another possibility would be that full length gp46 is needed for the proper localization of 
gp44, the minor capsid protein, in the procapsid in addition to its role as a chaperone 
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protein for capsid. Prior work in our lab has demonstrated that gp44 is essential for the 
phage, but not for SaPI1. 
While cleavage of gp46 is essential, N-terminal cleavage of gp47 is most notably 
not. Strain ST361 induction and plaque titering revealed that uncleavable gp47 behaves 
similarly to wild-type 80α. This suggests that the extra N-terminal 13 amino acids can be 
accommodated in the mature capsid without affecting capsid integrity. This result was 
surprising, and raises the question of why the phage has retained the cleavage motif. One 
possibility is that Prp functions as a chaperone for assembly in addition to its role as a 
protease, and this sequence is required for Prp binding. 
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Chapter 5 
 
 
Discussion 
 
 
 The purpose of this work was to characterize the interactions between 
staphylococcal phage 80α scaffold and capsid proteins and their roles in functional capsid 
assembly. Capsid assembly is a multi-step, complex process that is predicated by the 
proper assembly of a transient procapsid structure. Like all tailed bacteriophages, multiple 
copies of the internal scaffolding protein of 80α and the HK97-like major capsid proteins 
nucleate and self-assemble into a procapsid structure (Suhanovsky et al., 2015). 
Following a dramatic conformational change involving the dynamic “switch” of P132 in 
capsid, the procapsid expands, internal scaffold proteins are lost, DNA is packaged, and 
external capsid proteins rearrange, finally forming a mature icosahedral capsid that 
contains the entire 80α genome (Spilman et al., 2011). Unlike other tailed phages, the 
80α capsid assembly process can be hijacked by a mobile genetic element, SaPI1. SaPI1 
is able to redirect capsid assembly via two SaPI1 encoded genes, cpmA and cpmB, and 
instead of forming large capsids, preferentially forms smaller transducing particles that 
package SaPI DNA, in lieu of the 80α genome. Of particular note is the presence of an 
alternate SaPI1 scaffold protein, CpmB. It is this unique instance, where two distinct 
scaffold proteins interact with the same capsid protein in strikingly similar ways, which 
allowed us to explore not only location of the protein:protein interface between scaffold 
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and capsid, but also the roles of scaffold and capsid cleavage in the context of 80α and 
SaPI1.  
 
Investigating 80α scaffold and capsid protein interactions 
It was predicted by our lab that the 80α scaffold and capsid proteins formed a 
stable interface through the formation of a non-covalent salt bridge between a C-terminal 
R202 residue in scaffold and a glutamic acid in capsid (either residue E50 or E53). This 
prediction arose from a structural model, based upon the cryo-EM densities of SaPI1 
scaffold, CpmB, mapped onto a SaPI1 procapsid, but also from genetic evidence from 
previous work in our lab. This interaction was tested in various ways. First, the predicted 
alpha-helix in capsid, containing the EVME motif of interest (residues 50-53), was 
mutated separately at two sites, resulting in two single capsid mutant strains carrying an 
80α prophage with either an E50R or E53R capsid mutation. If our hypothesis had been 
correct, and the arginine-glutamic acid interaction was disrupted by either of these 
mutations, the 80α titer would likely have been reduced, if not completely abolished. 
However, both strains behaved similarly to wild-type 80α. The next step was introducing 
these same capsid mutations into a known lethal phage background, specifically gp46 
R202E. In these strains, the hypothesized salt bridge interaction was reversed, with the 
glutamic acid of capsid now residing in scaffold, and vice versa. Both double mutant 
strains were still non-viable, indicating that the lethal R202E phenotype was unable to be 
rescued by a putative re-established salt bridge.  
While this region of capsid does appear to directly interact with the C-terminal end 
of scaffold, based on the I203T second site suppressor mutants M52I and M52L, it fails 
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to establish the predicted salt-bridge interaction. However, there is a very similar motif 
nearby at residues 64-67, EPME. These motifs are not identical, however valine and 
proline are both non-polar and hydrophobic. While this similar motif is interesting, there 
are several issues that need to be resolved. First, when the I203T scaffold mutation was 
introduced into 80α, compensatory capsid mutations were found in the predicted helical 
region of capsid, at residue 52. Additionally, the EVME motif resides in an alpha-helix, 
whereas EPME appears to be in a beta strand, according to the predicted secondary 
structure created in PSIPRED. This poses a problem as the conserved residues of 
scaffold, RIIK, are also located in an alpha-helix. The long held assumption has been that 
scaffold and capsid are interacting via their respective C-terminal and N-terminal alpha-
helices. An I-TASSER model was constructed where 80α capsid was modeled onto the 
HK97-fold (Figure 10). This model appears to conflict with the PSIPRED predicted alpha-
helical regions of C-terminal scaffold and N-terminal capsid, as they both appear to be 
found on beta sheets. However, the I-TASSER model score of -0.6 suggest this model is 
not robust. Both the PSIPRED prediction, and the I-TASSER model underscore the need 
for an improved structural model of 80α scaffold:capsid interaction.  Additionally, the N-
terminus of phage scaffold has not been completely modeled, as a result, the EVME 
region could lie close to another region that establishes the salt bridge, however, with the 
current model this cannot be determined. 
  
Future directions for identifying the interface between scaffold and capsid proteins 
While molecular models can be helpful, currently all of these structures are based 
on predictions. Previously, our lab has used the bacterial adenylate cyclase two-hybrid 
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Figure 13: I-TASSER model of gp46 modeled onto the HK97-fold.  
 
Red indicates glutamic acid residues, yellow indicates methionine, green indicates valine, and pink indicates proline.  
The following residues are indicated on the model: EVME (residues 50-53) and EPME (residues 64-67). Geneious 6.1 
Bioinformatics software was also used in generating this image.
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system (BACTH) (Euromedex; Souffelweyersheim, France) to investigate the 
protein:protein interactions between scaffold and capsid. The BACTH system provides a 
much quicker screening tool than our current experimental approach which involves the 
very time intensive process of performing allelic exchanges, induction experiments and 
plaque titering assays.  
The BACTH system is based upon the reconstitution of adenylate cyclase activity 
through the interaction of two proteins fused to its fragmented catalytic domain (Karimova 
et al., 2000; Battesti et al., 2012). The catalytic domain of adenylate cyclase has two 
subdomains that are known to interact with each other, referenced here as T18 and T25. 
In the BACTH system used in our lab these two subdomains are inactive when they are 
separated. As such, the two subdomains can be fused to two different polypeptides in 
order to ascertain whether or not the polypeptides interact with each other. Upon 
transformation and coexpression of the two fusion proteins in an E. coli reporter strain 
lacking chromosomal adenylate cyclase, the two subdomains can heterodimerize due to 
an interaction between the polypeptides being tested, reconstituting the catalytic domain 
and resulting in active synthesis of cAMP. The newly synthesized cAMP can go on to bind 
the catabolite activator protein, CAP, which then binds to the promoter of the lactose or 
maltose operon, inducing gene expression (Battesti et al., 2012). Through this system, 
after creating the desired constructs, protein:protein interactions can be visualized 
through blue/white screening (β-galactosidase expression is regulated by cAMP/CAP) or 
plating on another appropriate indicator media, such as MacConkey agar, which indicates 
whether or not maltose is metabolized.  
54 
 
When the first 90 N-terminal residues of 80α capsid were fused to the T18 fragment 
and the last 70 C-terminal residues of 80α scaffold protein were fused to the T25 
fragment, the blue/white screening results were inconclusive. It is possible that these 
terminal fragments, particularly the N-terminus of capsid, do not assume the proper 
conformation. The next step in this process would be to screen the full-length proteins 
using the BACTH system, rather than the previously tested polypeptides. Besides the 
BACTH system, the more established yeast two-hybrid system could also be used to 
approach this problem. 
 
 
 
 
N-terminal cleavage of 80α scaffold and capsid proteins  
 
Previous studies have demonstrated that only cleaved capsid is present in mature 
80α virions. Phage scaffold, found in procapsids trapped by a mutation in terminase that 
blocks DNA packaging, is also N-terminally cleaved. However, the timing of this cleavage 
event is not well defined. Pre-cleaved scaffold and uncleavable capsid both have striking 
phenotypes: pre-cleaved scaffold is completely lethal, akin to the complete deletion of 
scaffold, and uncleavable capsid behaves like wildtype 80α. Future experiments are 
already in progress in which 80α lysogens carrying pre-cleaved capsid and uncleavable 
scaffold mutations will be induced and titered in order to observe their effects on phage 
capsid assembly. In addition to plaque assays, EMs of the resulting lysates would also 
be helpful in detecting any structural discrepancies generated by these mutations. Once 
all four cleavage strains have been tested, it will be interesting to see if the N-terminus of 
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capsid is necessary for scaffold-mediated chaperoning, or if scaffold is interacting with a 
different area of capsid for this purpose.  
In this work, we determined that similar residues at the C-termini of phage and 
SaPI1 scaffolds are required for proper procapsid assembly. However, the C-terminal 
residue of 80α scaffold R202 and the early N-terminal E50 or E53 residues in capsid were 
not involved in a proposed salt bridge interaction. This implies that these two alpha-
helices are not solely responsible for forming the interface between scaffold and capsid 
necessary for capsid assembly, although the I203T compensatory mutants indicate that 
these two regions do interact. Additionally, we have also determined that the timing of 
scaffold cleavage is significant. Pre-cleaved scaffold results in an inability to form viable 
phage progeny, analogous to the complete deletion of scaffold. Uncleavable capsid 
behaves comparably to wild-type 80α, indicating that N-terminal cleavage of capsid is not 
essential.  
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